PORT WASHINGTON, NY
4 risk indicators measuring financial stability and operational resilience
Sign in with your work email to view Tuckman-Chang indicators
Sign In — Free (10 views/day)THE MARFAN FOUNDATION INC, founded in 1981, is a community nonprofit that reported $5.5M in total revenue in fiscal year 2023. Revenue fell 33% from the prior year — a significant decline worth monitoring. Expenses of $6.6M exceeded revenue, resulting in a 21% operating deficit.
THE MARFAN FOUNDATION SAVES LIVES AND IMPROVES THE QUALITY OF LIFE OF INDIVIDUALS WITH GENETIC AORTIC AND VASCULAR CONDITIONS, INCLUDING MARFAN, LOEYS-DIETZ, AND VASCULAR EHLERS-DANLOS (VEDS) SYNDROMES WHILE CREATING COMMUNITY. WE PURSUE THE MOST INNOVATIVE RESEARCH AND MAKE SURE THAT IT RECEIVES PROPER FUNDING. WE FOSTER AN INFORMED PUBLIC AND EDUCATED PATIENT COMMUNITY TO INCREASE EARLY DIAGNOSIS AND ENSURE LIFE-SAVING TREATMENT. WE PROVIDE DEDICATED SUPPORT TO FAMILIES, CAREGIVERS, AND HEALTHCARE PROVIDERS.
RESEARCH -EXPENSES $2,248,000, GRANTS $1,090,810, REVENUE $0THE MARFAN FOUNDATION ADVANCES RESEARCH THAT SAVES LIVES AND DRAMATICALLY ENHANCES THE QUALITY OF LIFE FOR PEOPLE LIVING WITH MARFAN...
RESEARCH -EXPENSES $2,248,000, GRANTS $1,090,810, REVENUE $0THE MARFAN FOUNDATION ADVANCES RESEARCH THAT SAVES LIVES AND DRAMATICALLY ENHANCES THE QUALITY OF LIFE FOR PEOPLE LIVING WITH MARFAN SYNDROME, LOEYS-DIETZ SYNDROME, VEDS, AND RELATED GENETIC AORTIC AND VASCULAR CONDITIONS. OUR RESEARCH PROGRAM HAS ADVANCED SCIENCE SINCE 1981, FUNDING 176 RESEARCH GRANTS SINCE 1986. THE RESEARCH WE'VE SUPPORTED HAS HELPED REDUCE LIFE-THREATENING PROBLEMS, IDENTIFIED TREATMENTS THAT HAVE IMPROVED QUALITY OF LIFE, AND HELPED PEOPLE LIVE LONGER LIVES WITH MARFAN SYNDROME AND RELATED CONDITIONS. THE MARFAN FOUNDATION COLLABORATES WITH THE RESEARCH COMMUNITY AND ORGANIZATIONS TO IDENTIFY NEW THERAPIES AND TREATMENTS DOMESTICALLY AND AROUND THE GLOBE. THE FOUNDATION'S TWO-YEAR AND FOUR-YEAR GRANT MECHANISMS HELP ENSURE A PIPELINE OF DEDICATED FELLOWS, NEW INVESTIGATORS, AND FACULTY MEMBERS WHO ARE COMMITTED TO THE SCIENTIFIC DISCOVERY NECESSARY TO ADVANCE UNDERSTANDING OF RARE DISEASES. THE FOUNDATION CONVENES NATIONAL AND INTERNATIONAL RESEARCH CONFERENCES, FACILITATES COLLABORATIONS AMONG RESEARCHERS AND RESEARCH INSTITUTIONS, AND HOLDS SYMPOSIUMS IN THE US AND ABROAD TO FACILITATE THE SHARING OF RESEARCH FINDINGS THAT EXPEDITE PROGRESS. THE MARFAN FOUNDATION PARTNERS WITH GOVERNMENT AGENCIES AND OTHER HEALTHCARE ORGANIZATIONS TO ADVANCE ITS RESEARCH GOALS AND ADVOCATE FOR ADDITIONAL RESEARCH FUNDING FROM THE GOVERNMENT.
AWARD REFUNDS 35,083.
EDUCATION - EXPENSES $1,140,112, GRANTS $5,280, REVENUE $10THE MARFAN FOUNDATION AND ITS DIVISIONS (THE LOEYS-DIETZ SYNDROME FOUNDATION, THE VEDS MOVEMENT, AND THE GENTAC ALLIANCE) ARE THE PREEMINENT...
EDUCATION - EXPENSES $1,140,112, GRANTS $5,280, REVENUE $10THE MARFAN FOUNDATION AND ITS DIVISIONS (THE LOEYS-DIETZ SYNDROME FOUNDATION, THE VEDS MOVEMENT, AND THE GENTAC ALLIANCE) ARE THE PREEMINENT PROVIDERS OF INFORMATION AND PROGRAMS FOR AFFECTED INDIVIDUALS AND FAMILIES WITH GENETIC AORTIC AND VASCULAR CONDITIONS, MEDICAL PROFESSIONALS, RESEARCHERS, AND THE GENERAL PUBLIC. WE REACH ONE MILLION PEOPLE ANNUALLY WITH OUR EDUCATIONAL RESOURCES. THE MARFAN FOUNDATION OFFERS A WEALTH OF MEDICAL AND QUALITY-OF-LIFE INFORMATION FOR PEOPLE LIVING WITH MARFAN SYNDROME, LOEYS-DIETZ, VASCULAR EHLERS-DANLOS (VEDS), AND RELATED CONDITIONS IN MANY LANGUAGES THROUGH ITS HELP & RESOURCE CENTER, WHICH REACHES 5,000 PEOPLE EVERY YEAR -- DIRECTED BY IN-HOUSE NURSES AND A BILINGUAL MANAGER WHO ANSWER QUESTIONS BY PHONE AND EMAIL, AND THROUGH ITS COMPREHENSIVE WEBSITE, WHICH IS AVAILABLE IN 25 LANGUAGES. THE FOUNDATION OFFERS SPECIALIZED RESOURCES FOR CHILDREN, TEENS, PARENTS, TEACHERS, AND SCHOOL NURSES. IN ADDITION, THE FOUNDATION IS FOCUSED ON MENTAL HEALTH, OFFERING A RANGE OF OPPORTUNITIES, INCLUDING VIRTUAL SUPPORT GROUPS, VIDEOS, WEBINARS, AND OTHER CONTENT. THE MARFAN FOUNDATION FOCUSES ON EXPANDING HEALTH EQUITY AND ACCESS TO CARE FOR THE CONSTITUENTS WE SERVE GLOBALLY.
Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency
Sign in to view Trantor Score and financial metrics
Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)
Sign In — Free (10 views/day)| 2023 | 2022 | Change | |
|---|---|---|---|
| Revenue | $5,486,020 | $8,195,380 | -0.3% |
| Expenses | $6,646,776 | $6,758,497 | 0.0% |
| Net Income | $-1,160,756 | $1,436,883 | -1.8% |
Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics
Financial Distress Indicator
Liquidity & Cash Position
Sign in to view all financial metrics
Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics
Sign In| Name | Title | Hours/Week | Role | Reportable Comp | Other Comp | Total |
|---|---|---|---|---|---|---|
| BERT MEDINA | CHAIR | 8.00 |
Officer
Director
|
$0 | $0 | $0 |
| CORY A EAVES | IMMEDIATE PAST CHAIR | 1.00 |
Officer
Director
|
$0 | $0 | $0 |
| CARYN E KAUFFMAN CPA | TREASURER | 3.00 |
Officer
Director
|
$0 | $0 | $0 |
| PATRICIA MCCABE ESTRADA | SECRETARY | 1.00 |
Officer
Director
|
$0 | $0 | $0 |
| JERRY L LERMAN | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| ALAN BRAVERMAN MD | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| BRANDY BANKS HOTCHKISS | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| GIL BASHE | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| JOAQUIN RAMOS JR | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| JEFFREY C LESAGE | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| SINCLAIR LI | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| DAVID WARREN | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| ANDREW TOY | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| GARY KAUFFMAN | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| JON TULLIS | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| SCOTT D AVITABILE ESQ | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| ANTHONY YASICK MD | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| JUAN BOWEN MD | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| RAY CHEVALLIER | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| JAMES PRUTOW | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| DAWN REINER | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| MICHAEL L WEAMER | PRES/CEO | 35.00 |
Officer
|
$457,343 | $27,314 | $484,657 |
| INDERJEET KAUR CPA | CHIEF FINANCIAL OFFICER | 35.00 |
Officer
|
$154,779 | $17,371 | $172,150 |
| JUDITH GIBALDI | CHIEF OPERATIONS OFFICER | 35.00 |
Officer
|
$118,377 | $27,314 | $145,691 |
| HELAINE BARUCH | CHIEF DEVELOPMENT OFFICER | 35.00 |
Highest
|
$243,822 | $17,371 | $261,193 |
| JOSEPHINE GRIMA | CHIEF SCIENCE OFFICER | 35.00 |
Highest
|
$207,595 | $17,371 | $224,966 |
| EILEEN NOVINS | CHIEF GLOBAL BUSINESS DEVEL. OFFICER | 35.00 |
Highest
|
$189,021 | $17,371 | $206,392 |
| LAUREN E MAY | DIRECTOR OF RESEARCH | 35.00 |
Highest
|
$131,937 | $17,371 | $149,308 |
| KIMBERLY K HUDDLESTON | VP. OF DEVELOPMENT | 35.00 |
Highest
|
$117,954 | $17,371 | $135,325 |
| Year | Revenue | Expenses | Assets | Net Income |
|---|---|---|---|---|
| 2025 | No data | No data | No data | No data |
| 2024 | $5,486,020 | $6,646,776 | $18,118,070 | $-1,160,756 |
| 2023 | $8,195,380 | $6,758,497 | $18,561,612 | $1,436,883 |
| 2022 | $9,814,628 | $4,705,271 | $16,600,923 | $5,109,357 |
| 2021 | $4,898,166 | $4,891,164 | $12,467,539 | $7,002 |
| 2020 | $3,889,456 | $6,171,617 | $11,146,771 | $-2,282,161 |
| 2019 | $4,704,278 | $5,465,717 | $12,076,553 | $-761,439 |
Compare THE MARFAN FOUNDATION INC with other nonprofits in New York and across the country.